Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the prescription ...

Express Scripts sues FTC over report blasting pharmacy middlemen by Nathaniel Weixel - 09/17/24 2:04 PM ET. by Nathaniel Weixel - 09/17/24 2:04 PM ET.

Express Scripts, which Cigna acquired for $67 billion six years ago, brought in $26.6 billion in revenue in the second quarter — 44% of Cigna’s entire topline.

Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the agency’s July report on the PBM industry was biased and defamatory ...

Express Scripts has filed suit against the Federal Trade Commission (FTC), demanding that the agency retract a damning report on the pharmacy benefit management industry. In the lawsuit, which was ...

Express Scripts, a subsidiary of The Cigna Group, has filed a federal lawsuit against the US Federal Trade Commission (FTC) over a July 2024 report claiming that the report is “false and ...

Express Scripts said the FTC has chosen "to ignore the facts and score political points, rather than focus on its duty to protect consumers." Far higher costs in U.S.

Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a report it made in July 2024 that said the pharmacy benefit management ...

Express Scripts filed a lawsuit against the FTC earlier this week demanding the agency retract its July report, which the company said was “unfair, biased, erroneous and defamatory.” ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially”… ...

FTC sues insulin middlemen, saying they pocket billions while patients face high costs. Updated September 22, 2024 6:23 PM ET Originally published September 21, ... Cigna's Express Scripts, ...

According to Express Scripts, the FTC disregarded documents provided by the PBMs showing that the companies lower prescription drug costs for payers. The lawsuit also accuses Khan, who has led the ...